YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Epogen

Epogen, Aranesp and Procrit Linked to Potentially Fatal Blood Clots

Feb 27, 2008 | Parker Waichman Alonso LLP
Epogen, Aranesp and Procrit,  anemia drugs used to treat cancer patients, have been linked to a higher risk of a potentially fatal type of blood...

Aranesp, Epogen and Procrit Policy Justified, Medicare Official Says.

Feb 11, 2008 | Parker Waichman Alonso LLP
More trouble for Aranesp, Epogen and Procrit.  Senior Medicare official Dr. Barry Straube said evidence—including two studies—is...

Procrit, Aranesp and Epogen to See More FDA Scrutiny After Two Studies Show Increased Tumor Growth in Some Cancer Patients Treated with ESAs

Jan 3, 2008 | Parker Waichman Alonso LLP
Two new studies suggest that Procrit, Aranesp and Epogen could carry more risks than first thought, prompting the Food & Drug Administration...

Aranesp, Epogen and Procrit Linked to Leukemia in Some Patients

Dec 11, 2007 | Parker Waichman Alonso LLP
Aranesp, Epogen and Procrit have been linked to yet another deadly side effect. New research suggests that the anemia drugs, known as...

Amgen Warns of More Aranesp Lable Changes

Dec 10, 2007 | Parker Waichman Alonso LLP
Aranesp, an anemia drug often used to treat chemotherapy patients, could soon have safety information on its label updated yet again, the...

Aranesp Study Shows Little Benefit for Breast Cancer Patients, Possibly Higher Rates of Death, Tumor Growth

Dec 3, 2007 | Parker Waichman Alonso LLP
Aranesp, an anemia drug, does not appear to benefit breast cancer patients.  Amgen Inc., maker of Aranesp, recently said interim results...

Aranesp, Epogen, Procrit Label Updated Over Safety Concerns

Nov 8, 2007 | Parker Waichman Alonso LLP
The labels of Aranesp, Epogen and Procrit, drugs used to treat anemia, are being updated to include new dosage guidelines and specific information on...

Proposed Aranesp, Epogen, Procrit Dosage Limit Rejected by FDA Advisory Panel

Sep 12, 2007 | Parker Waichman Alonso, LLP
An advisory panel has concluded that Amgen's anemia medications should not be subject to a new dosage limit proposed by the Food & Drug...

Proposed Aranesp, Epogen, Procrit Dosage Limit Rejected by FDA Advisory Panel

Sep 12, 2007 | Parker Waichman Alonso, LLP
An advisory panel has concluded that Amgen's anemia medications should not be subject to a new dosage limit proposed by the Food & Drug...

Controversy over Aranesp, Epogen and Procrit to Be Addressed by FDA Panel

Sep 10, 2007 | Parker Waichman Alonso, LLP
Aranesp, Epogen and Procrit, drugs given to anemia patients suffering end-stage kidney failure, will be taken up by a Food & Drug Administration...

Page 2/3 [first] [prev] 1 2 3 [next] [last]

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News